SCHEMBL30721706

SCHEMBL30721706

NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)O)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 6/20 0.65
▸ F2 P00734 1/20 0.63
▸ OPRD1 P41143 4/20 0.60
▸ SLC6A2 P23975 1/20 0.59
▸ NTSR2 O95665 2/20 0.57
▸ NTSR1 P30989 2/20 0.57
▸ SORT1 Q99523 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30721707 0.93 F2 (0.71) OPRM1F2OPRD1SLC6A2
SCHEMBL31679387 0.92 OPRM1 (0.66) OPRM1F2OPRD1SLC6A2
SCHEMBL30444236 0.91 SLC6A2 (0.62) OPRM1F2OPRD1SLC6A2NTSR2
SCHEMBL31114540 0.91 OPRM1 (0.64) OPRM1F2OPRD1SLC6A2NTSR2
SCHEMBL31114390 0.89 OPRM1 (0.64) OPRM1F2OPRD1SLC6A2NTSR2
SCHEMBL30273400 0.89 OPRM1 (0.64) OPRM1F2OPRD1SLC6A2NTSR2
SCHEMBL31114383 0.89 OPRM1 (0.68) OPRM1F2OPRD1NTSR2NTSR1
Lysine SCHEMBL27634053 0.88 OPRM1 (0.72) OPRM1F2OPRD1SLC6A2NTSR2
SCHEMBL30609950 0.88 F2 (0.67) OPRM1F2OPRD1SLC6A2NTSR2
SCHEMBL30497929 0.88 OPRM1 (0.64) OPRM1F2OPRD1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117343137-B Oyster oligopeptide and compound thereof, preparation and application thereof in treating liver fibrosis diseases 大连深蓝肽科技研发有限公司 2024-08-06 — — CN claimed
CN-117343137-A Oyster oligopeptide and compound thereof, preparation and application thereof in treating liver fibrosis diseases 大连深蓝肽科技研发有限公司 2024-01-05 — — CN claimed
CN-117343137-B Oyster oligopeptide and compound thereof, preparation and application thereof in treating liver fibrosis diseases 大连深蓝肽科技研发有限公司 2024-08-06 — — CN disclosed
CN-117343137-B Oyster oligopeptide and compound thereof, preparation and application thereof in treating liver fibrosis diseases 大连深蓝肽科技研发有限公司 2024-08-06 — — CN disclosed
CN-117343137-A Oyster oligopeptide and compound thereof, preparation and application thereof in treating liver fibrosis diseases 大连深蓝肽科技研发有限公司 2024-01-05 — — CN disclosed
CN-117343137-A Oyster oligopeptide and compound thereof, preparation and application thereof in treating liver fibrosis diseases 大连深蓝肽科技研发有限公司 2024-01-05 — — CN disclosed
Send feedback